In the study, 9,711 patients who underwent hip and knee replacements were split into two groups. One group was treated strictly with aspirin after the surgery, while the other was only given the anticoagulant enoxaparin.
After 90 days, researchers evaluated both groups and found that venous thromboembolism occurred in 256 patients. The group treated strictly with aspirin were nearly twice as likely to develop VTE, according to the study.
The aspirin group saw a 3.45 percent VTE rate, while only 1.82 percent of the enoxaparin group experienced VTE.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
